What Has Been the Growth of the Erectile Dysfunction Market So Far?
The erectile dysfunction market has seen considerable growth due to a variety of factors.
• The market size for erectile dysfunction has seen significant growth in recent years. The projection shows an increase from $2.46 billion in 2024 to $2.69 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%.
The historical growth is credited to factors such as an increase in cardiovascular diseases, a higher prevalence of diabetes, better awareness of erectile dysfunction as a medical issue, an elderly population resulting in more cases of erectile dysfunction, and an increased preference for individualized treatment plans.
What Is the Forecasted Market Size and Growth Rate for The Erectile Dysfunction Market Size In The Coming Years?
The erectile dysfunction market is expected to maintain its strong growth trajectory in upcoming years.
• The market for erectile dysfunction is anticipated to experience substantial growth in the forthcoming years, expanding to $3.78 billion in 2029 with a compound annual growth rate (CAGR) of 8.9%.
This growth over the prediction span can be credited to factors such as an upsurge in psychological issues, accelerating rates of obesity and metabolic conditions, increasing demand for non-surgical erectile dysfunction treatments, a rise in patient discussions regarding sexual health and an increase in government initiatives focusing on men’s health and lifestyle-related risks. Notable trends during this forecast period involve the growth of online pharmacies dealing in medicines for erectile dysfunction, progress in the field of penile implant technologies, technological enhancements in diagnosing erectile dysfunction, innovative treatment approaches addressing the underlying reasons for erectile dysfunction, and the emergence of effective phosphodiesterase type 5 inhibitors.
What Factors Are Driving Growth In The Erectile Dysfunction Market?
The escalating occurrence of illnesses connected to lifestyle choices is projected to fuel the expansion of the erectile dysfunction market. Such health problems usually stem from unhealthy habits such as inadequate nutrition, insufficient physical activity, smoking, and excessive consumption of alcohol. The proliferation of these diseases can be attributed to the surge in sedentary behavior, poor eating habits, high stress levels, and unhealthy behaviors, including smoking and overconsumption of alcohol. Erectile dysfunction (ED) acts as an initial alarm for lifestyle-related illnesses like cardiovascular diseases and diabetes, emphasizing the importance of timely medical attention and the adoption of a healthier lifestyle. For instance, the World Obesity Federation, a non-profit organization based in the UK, reported in May 2022 that by 2030, a billion individuals worldwide – including one in every five women and one in seven men – are anticipated to be living with obesity. This figure is predicted to rise further, with 4 billion people – equivalent to 51% of the global population – likely to be overweight or obese by 2035. Thus, the escalating occurrence of lifestyle-related diseases is expected to boost the growth of the erectile dysfunction market.
What Are The Main Segments Of The Global Erectile Dysfunction Market?
The erectile dysfunction market covered in this report is segmented –
1) By Product: Drugs, Devices
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channels
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Pharmacies, Other End Users
Subsegments:
1) By Drugs: Phosphodiesterase Type 5 (PDE5) Inhibitors, Hormone Therapy, Injectable Medications, Topical Medications
2) By Devices: Vacuum Erection Devices (VEDs), Penile Implants, Shockwave Therapy Devices
Pre-Book The Erectile Dysfunction Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Erectile Dysfunction Market?
Major players in the erectile dysfunction market are shifting their focus towards the development of innovative products such as over-the-counter (OTC) gels. These products are created to offer easy-to-access and simple treatment solutions to individuals suffering from erectile dysfunction. This strategy is aimed at broadening their market presence and meeting the unfulfilled demands of patients. The over-the-counter (OTC) gels are used as a topical medicine that can be purchased without prescription and used to treat various conditions by applying it directly on the skin. For example, Haleon plc, a consumer healthcare firm based in the UK, introduced Eroxon in September 2024. It is the first ever FDA-approved OTC gel for the treatment of erectile dysfunction (ED). The product is innovative and offers a quick and non-invasive solution for ED, designed to enhance convenience and access for patients. Its simple usage as a topical application eliminates the need for consuming oral medications and minimizes the chance of systemic side effects.
Who Are the Key Players In The Erectile Dysfunction Market?
Major companies operating in the erectile dysfunction market are:
• Pfizer Inc.
• Bayer AG
• Dong-A Socio Holdings Co. Ltd.
• Sanofi S.A.
• GlaxoSmithKline plc
• Eli Lilly and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Limited
• Boston Scientific Corporation
• Sandoz International GmbH
• Sun Pharmaceutical Industries Limited
• Coloplast Corporation
• Dr. Reddy's Laboratories Limited
• Cipla Limited
• Ferring Pharmaceuticals A/S
• Endo International plc
• Zydus Lifesciences Limited
• Lupin Limited
• Hims & Hers Health Inc.
• Cadila Pharmaceuticals Limited
• VIVUS Inc.
• Rigicon Inc.
• Petros Pharmaceuticals Inc.
• Futura Medical plc
• Apricus Biosciences Inc.
• Pos-T-Vac Medical Inc.
• Initiator Pharma A/S
What Is The Most Dominant Region In The Erectile Dysfunction Market?
North America was the largest region in the erectile dysfunction market in 2024. The regions covered in the erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
